HSD17B13-IN-36 (compound 116) serves as a potent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of <0.1 µM with estradiol as substrates. This compound is significant in the management of nonalcoholic fatty liver diseases (NAFLDs), including NASH (nonalcoholic steatohepatitis) [1].
Molecular Weight:
433.43
CAS Number:
[2730027-86-6]
Formula:
C20H17F2N3O4S
Target:
Dehydrogenase
T86625
* VAT and and shipping costs not included. Errors and price changes excepted
